Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-01-11 @ 9:44 PM
Study NCT ID:
NCT05207904
Status:
UNKNOWN
Last Update Posted:
2022-01-26
First Post:
2021-12-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases
Sponsor:
Organization: